1209 related articles for article (PubMed ID: 8530330)
1. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
[TBL] [Abstract][Full Text] [Related]
2. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.
Melartin TK; Rytsälä HJ; Leskelä US; Lestelä-Mielonen PS; Sokero TP; Isometsä ET
J Clin Psychiatry; 2002 Feb; 63(2):126-34. PubMed ID: 11874213
[TBL] [Abstract][Full Text] [Related]
3. The spectrum of substance abuse in bipolar disorder: reasons for use, sensation seeking and substance sensitivity.
Bizzarri JV; Sbrana A; Rucci P; Ravani L; Massei GJ; Gonnelli C; Spagnolli S; Doria MR; Raimondi F; Endicott J; Dell'Osso L; Cassano GB
Bipolar Disord; 2007 May; 9(3):213-20. PubMed ID: 17430295
[TBL] [Abstract][Full Text] [Related]
4. Preliminary observations of DSM-III-R axis I comorbidity in men with paraphilias and paraphilia-related disorders.
Kafka MP; Prentky RA
J Clin Psychiatry; 1994 Nov; 55(11):481-7. PubMed ID: 7989281
[TBL] [Abstract][Full Text] [Related]
5. Anxiety disorders in adults treated by hemodialysis: a single-center study.
Cukor D; Coplan J; Brown C; Friedman S; Newville H; Safier M; Spielman LA; Peterson RA; Kimmel PL
Am J Kidney Dis; 2008 Jul; 52(1):128-36. PubMed ID: 18440682
[TBL] [Abstract][Full Text] [Related]
6. Association of antisocial personality disorder and substance disorder morbidity in a clinical sample.
Westermeyer J; Thuras P
Am J Drug Alcohol Abuse; 2005; 31(1):93-110. PubMed ID: 15768573
[TBL] [Abstract][Full Text] [Related]
7. Depression, anxiety, and somatoform disorders: vague or distinct categories in primary care? Results from a large cross-sectional study.
Hanel G; Henningsen P; Herzog W; Sauer N; Schaefert R; Szecsenyi J; Löwe B
J Psychosom Res; 2009 Sep; 67(3):189-97. PubMed ID: 19686874
[TBL] [Abstract][Full Text] [Related]
8. Comorbidity of axis I psychiatric disorders in bulimia nervosa.
Brewerton TD; Lydiard RB; Herzog DB; Brotman AW; O'Neil PM; Ballenger JC
J Clin Psychiatry; 1995 Feb; 56(2):77-80. PubMed ID: 7852257
[TBL] [Abstract][Full Text] [Related]
9. The effect of comorbid substance use disorders on treatment outcome for anxiety disorders.
McEvoy PM; Shand F
J Anxiety Disord; 2008 Aug; 22(6):1087-98. PubMed ID: 18164585
[TBL] [Abstract][Full Text] [Related]
10. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
11. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
[TBL] [Abstract][Full Text] [Related]
12. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
[TBL] [Abstract][Full Text] [Related]
13. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
Lee JH; Dunner DL
Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
[TBL] [Abstract][Full Text] [Related]
14. Depression in adults with intellectual disability: symptoms and challenging behaviour.
Hurley AD
J Intellect Disabil Res; 2008 Nov; 52(11):905-16. PubMed ID: 18680532
[TBL] [Abstract][Full Text] [Related]
15. Phenomenology and severity of major depression and comorbid lifetime anxiety disorders in primary medical care practice.
Brown C; Schulberg HC; Shear MK
Anxiety; 1996; 2(5):210-8. PubMed ID: 9160625
[TBL] [Abstract][Full Text] [Related]
16. Relation between depression and anxiety in dystonic patients: implications for clinical management.
Moraru E; Schnider P; Wimmer A; Wenzel T; Birner P; Griengl H; Auff E
Depress Anxiety; 2002; 16(3):100-3. PubMed ID: 12415533
[TBL] [Abstract][Full Text] [Related]
17. Anxiety disorders among patients with co-occurring bipolar and substance use disorders.
Kolodziej ME; Griffin ML; Najavits LM; Otto MW; Greenfield SF; Weiss RD
Drug Alcohol Depend; 2005 Nov; 80(2):251-7. PubMed ID: 15876498
[TBL] [Abstract][Full Text] [Related]
18. Social anxiety symptoms across diagnoses among outpatients attending a tertiary care mood and anxiety disorders service.
Graystone HJ; Garner MJ; Baldwin DS
J Affect Disord; 2009 Apr; 114(1-3):305-9. PubMed ID: 18656267
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence of depressive disorders in children and adolescents attending primary care. A survey with the Aquitaine Sentinelle Network].
Mathet F; Martin-Guehl C; Maurice-Tison S; Bouvard MP
Encephale; 2003; 29(5):391-400. PubMed ID: 14615688
[TBL] [Abstract][Full Text] [Related]
20. Reasons for substance use and vulnerability factors in patients with substance use disorder and anxiety or mood disorders.
Bizzarri JV; Rucci P; Sbrana A; Gonnelli C; Massei GJ; Ravani L; Girelli M; Dell'osso L; Cassano GB
Addict Behav; 2007 Feb; 32(2):384-91. PubMed ID: 16797139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
